跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Nasoflo - Philippines FDA Drug Approval Details
Approvals
/
Philippines FDA
/
Nasoflo
Approved
STANDARD
Nasoflo
Square Pharmaceuticals Ltd.
🇵🇭 Food and Drug Administration - Philippines
Approval Date
Jul 14, 2025
Approval ID
e30e1d9f7037f80d
Company
Square Pharmaceuticals Ltd.
Type
Standard
Approval Details
Approval Id
e30e1d9f7037f80d
Drug Approval Philippines Name
Nasoflo
Product Name
Nasoflo
Registration Number
DR-XY34848
Brand Name
Nasoflo
Generic Name
Fluticasone Propionate
Dosage Form
Aqueous Nasal Spray
Dosage Strength
50 mcg
Manufacturer
Square Pharmaceuticals Ltd.
Importer
UNILAB, Inc.
Distributor
UNILAB, Inc.
Company Detail Path
/organization/square-pharmaceuticals-kenya-epz-ltd
Issuance Date
22 July 2023
Expiry Date
28 August 2028
Pharmacologic Category
Nasal Corticosteroid
Classification
Prescription Drug (RX)
Active Ingredients
Approved
Quick Info
Agency
Philippines FDA
Country
🇵🇭
Approval Date
Jul 14, 2025
Approval ID
e30e1d9f7037f80d
Type
Standard
Back to Philippines FDA Approvals